5. Sueblinvong V, Weiss DJ. Stem cells and cell therapy approaches in lung
biology and diseases. Transl Res. 2010; 156(3): 188-205. doi:
10.1016/j.trsl.2010.06.007.
6. Mora AL, Rojas M. Adult stem cells for chronic lung diseases.
Respirology. 2013; 18(7): 1041-6. doi: 10.1111/resp.12112.
7. Stessuk T, Ruiz MA, Greco OT, Bilaqui A, Ribeiro-Paes MJ, Ribeiro-
Paes JT. Phase I clinical trial of cell therapy in patients with advanced chronic
obstructive pulmonary disease: Follow-up of up to 3 years. Rev Bras Hematol
Hemoter. 2013; 35(5): 352-7. doi: 10.5581/1516-8484.20130113.
8. Jones CP, Rankin SM. Bone marrow-derived stem cells and respiratory
disease. Chest. 2011; 140(1): 205-11. doi: 10.1378/chest.10-2348.
9. Cruz FF, Borg ZD, Goodwin M. Systemic administration of human bone
marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates
Aspergillus hyphal extract-induced allergic airway inflammation in
immunocompetent mice. Stem Cells Transl Med. 2015; 4(11): 1302-16. doi:
10.5966/sctm.2014-0280.
10. Braza F, Dirou S, Forest V, et al. Mesenchymal stem cells induce
suppressive macrophages through phagocytosis in a mouse model of asthma.
Stem Cells. 2016; 34(7): 1836-45. doi: 10.1002/stem.2344.
11. Bonfeld T, Sutton M, Lennon D, Caplan A. Mesenchymal stem cells:
New directions in treating asthma (THER2P.955). J Immunol. 2015; 194 (1
Supplement): 6-67.
12. Ge X, Bai C, Yang J, Lou G, Li Q, Chen R. Effect of mesenchymal stem
cells on inhibiting airway remodeling and airway inflammation in chronic
asthma. J Cell Biochem. 2013; 114(7): 1595-1605. doi: 10.1002/jcb.24501.
13. Mohammadian M et al. Effect of bone marrow derived mesenchymal
stem cells on lung pathology and inflammation in ovalbumin-induced asthma in
mouse. Iranian journal of basic medical sciences. 2016; 19(1): 55-63.
14. Cho K-S et al. Adipose-Derived stem cells ameliorate allergic airway
inflammation by inducing regulatory T cells in a mouse model of asthma.
Mediators of Inflammation. 2014; 2014: 1-12.
